Posted Oct. 26, 2011 at 11:23 a.m.
Biogen
Research Triangle Park, N.C. — In a two-year study, a twice daily dosage reduced the annualized relapse rate for MS patients by 44 percent compared to placebo. At three times a day dosage, relapse rates were reduced by 51 percent....Copyright 2013 MedCity. All rights reserved.
Biogen reports progress on multiple sclerosis drug
Post a comment
Print this blog postE-mail blog post
Share
Biogen
Research Triangle Park, N.C. — In a two-year study, a twice daily dosage reduced the annualized relapse rate for MS patients by 44 percent compared to placebo. At three times a day dosage, relapse rates were reduced by 51 percent....Copyright 2013 MedCity. All rights reserved.
Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
At last! Sprint 4G service formally launches in Triangle- Big Blue's layoff total climbs in RTP; North America total surges past 2,800
- Big Blue layoff count nears 2,800 in North America alone
- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts
- Workers 50+ take biggest hit among 14% reduction in IBM marketing group
- 'Anxiety and disruption:' IBM's form letter for layoffs